Literature DB >> 15151185

Characteristics of the actions of neurotensin on motor reactions in rats in response to positive and negative conditioned signals.

N P Shugalev1, N G Yamshchikova, A S Ol'shanskii, A V Stavrovskaya.   

Abstract

This study addressed the effects of microinjections of neurotensin into the caudate nucleus and substantia nigra on the performance of motor reactions in response to positive and negative conditioned signals, as well as the post-effects of microinjections in subsequent experiments. Neurotensin had positive effects on the extinction of non-reinforced motor reactions. Neurotensin had no effect on the number of motor responses to the non-reinforced signal, though the number decreased in subsequent experiments. There was an increase in the latent period of responses as compared with controls. The effect of neurotensin at the level of the caudate nucleus was more marked than that at the level of the substantia nigra. Neurotensin microinjections had no marked effect on performance of conditioned responses to positive signals. The behavioral effects of neurotensin are associated with normalization of the interactions of the brain's monoaminergic systems. It is suggested that the positive actions of neurotensin on extinction of motor responses to negative signals result from the formation of a contextual conditioned emotional state in the animals, this facilitating optimization of conditioned reflex activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151185     DOI: 10.1023/b:neab.0000012810.07519.e3

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  11 in total

1.  Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area.

Authors:  T R Werkman; C G Kruse; H Nievelstein; S K Long; W J Wadman
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine.

Authors:  P P Rompré
Journal:  Eur J Pharmacol       Date:  1997-06-11       Impact factor: 4.432

3.  Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin.

Authors:  P W Kalivas; C B Nemeroff; A J Prange
Journal:  Eur J Pharmacol       Date:  1982-03-26       Impact factor: 4.432

4.  Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.

Authors:  B Levant; C B Nemeroff
Journal:  J Pharmacol Exp Ther       Date:  1992-07       Impact factor: 4.030

5.  Neurotensin: a new 'reward peptide'.

Authors:  P W Glimcher; D H Margolin; A A Giovino; B G Hoebel
Journal:  Brain Res       Date:  1984-01-16       Impact factor: 3.252

6.  Atypical neuroleptic-like behavioral effects of neurotensin.

Authors:  F B Jolicoeur; M A Gagné; R Rivest; A Drumheller; S St-Pierre
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

7.  Autoradiographic distribution of [3H]neurotensin receptors in the brains of superoxide dismutase transgenic mice.

Authors:  J L Cadet; K Kujirai; E Carlson; C J Epstein
Journal:  Synapse       Date:  1993-05       Impact factor: 2.562

8.  Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.

Authors:  K Fuxe; W T O'Connor; T Antonelli; P G Osborne; S Tanganelli; L F Agnati; U Ungerstedt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

9.  Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons.

Authors:  T Hökfelt; B J Everitt; E Theodorsson-Norheim; M Goldstein
Journal:  J Comp Neurol       Date:  1984-02-01       Impact factor: 3.215

10.  Effects of neurotensin on midbrain dopamine neurons: are they mediated by formation of a neurotensin-dopamine complex?

Authors:  W X Shi; B S Bunney
Journal:  Synapse       Date:  1991-11       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.